Phibro Animal Health | PAHC - 净收入

金融业

USD

USD 1.5B

现金及等价物

USD 61.42M

USD 240.42M

USD 935.51M

USD 316.47M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 385.48M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 597.69M

USD 1.51B

USD 27.46M

USD 361.83M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 534.88M

贸易债权人

USD 127.31M

应收帐款人

USD 215.87M

	净收入	更改		日
Align Technology	USD 108.29M		4.48M	2026-06
ANI Pharmaceuticals	USD 24.71M		4.78M	2026-06
Aurora Cannabis	CAD -71.1M		72.92M	2026-03
Bristol-Myers Squibb	USD 3.32B		640M	2026-06
Canopy Growth	CAD -157.11M		94.49M	2026-03
Corcept Therapeutics	USD 42.14M		73.9M	2026-06
Eli Lilly	USD 7.1B		301M	2026-06
Henry Schein	USD 94M		13M	2026-06
Idexx Laboratories	USD 338.41M		59.97M	2026-06
Knight Therapeutics	CAD -3.79M		8.83M	2025-09
Merck	USD -1.34B		2.9B	2026-06
Nektar Therapeutics	USD -44.9M		8.82M	2026-03
Pacira	USD 4.65M		1.74M	2026-06
Phibro Animal Health	USD 27.46M		932K	2025-12
Prestige Brands	USD 38.54M		15.39M	2026-06
Supernus Pharmaceuticals	USD -58.37M		56.08M	2026-06
Zoetis	USD 691M		90M	2026-06